Furiex Pharma Slips To Loss Amid Revenue Slump, Misses Estimate - Quick Facts

(RTTNews) - Furiex Pharmaceuticals Inc (FURX) Wednesday reported first-quarter net loss of $13 million or $1.25 per share compared with a profit of $9 million or $0.82 per share last year.

Revenues for the quarter were $6.4 million compared with $39.3 million in the prior year, when the company benefited from milestone payments.

Analysts polled by Thomson Reuters estimated a loss of $0.63 per share on revenues of $10.01 million for the quarter. Analysts' estimates typically exclude special items.

Expenses for the quarter totaled $17.8 million compared with $29 million a year ago.